Fullerene-based antioxidants and neurodegenerative disorders
- 1 July 2001
- journal article
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 7 (3) , 243-246
- https://doi.org/10.1016/s1353-8020(00)00064-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Inhibition of Nitric Oxide Synthase Isoforms by Tris-Malonyl-C60-Fullerene AdductsArchives of Biochemistry and Biophysics, 2000
- Rapid microplate assay for superoxide scavenging efficiencyJournal of Neuroscience Methods, 2000
- C3‐Fullero‐tris‐Methanodicarboxylic Acid Protects Cerebellar Granule Cells from ApoptosisJournal of Neurochemistry, 2000
- C3‐Fullero‐tris‐methanodicarboxylic acid protects epithelial cells from radiation‐induced anoikia by influencing cell adhesion abilityFEBS Letters, 1999
- Carboxyfullerene Prevents Iron‐Induced Oxidative Stress in Rat BrainJournal of Neurochemistry, 1999
- Distinct Mechanisms Underlie Neurotoxin-Mediated Cell Death in Cultured Dopaminergic NeuronsJournal of Neuroscience, 1999
- Blockage of apoptotic signaling of transforming growth factor‐β in human hepatoma cells by carboxyfullereneEuropean Journal of Biochemistry, 1998
- Carboxyfullerenes as neuroprotective agentsProceedings of the National Academy of Sciences, 1997
- Buckminsterfullerenol Free Radical Scavengers Reduce Excitotoxic and Apoptotic Death of Cultured Cortical NeuronsNeurobiology of Disease, 1996